Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,110.90
+0.10 (0.01%)
Jun 19, 2026, 3:29 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 102.39 billion as of June 18, 2026. Its market cap has increased by 36.98% in one year.
Market Cap
102.39B
Enterprise Value
118.26B
Revenue
48.59B
Ranking
n/a
PE Ratio
18.41
Stock Price
1,110.90
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 102.39B, an increase of 1,266.36%. That is a compound annual growth rate of 10.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 102.39B | 23.39% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 211.00B |
| Eris Lifesciences | 200.70B |
| NATCO Pharma | 159.23B |
| Cohance Lifesciences | 155.26B |
| Alembic Pharmaceuticals | 149.98B |
| Alivus Life Sciences | 131.37B |
| Sudeep Pharma | 95.21B |
| Akums Drugs and Pharmaceuticals | 92.58B |